.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
AstraZeneca
Fish and Richardson
Dow
US Army
Merck
Julphar
Healthtrust
Queensland Health
McKinsey

Generated: July 21, 2017

DrugPatentWatch Database Preview

Clonidine - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for clonidine and what is the scope of clonidine freedom to operate?

Clonidine
is the generic ingredient in nine branded drugs marketed by Tris Pharma Inc, Aveva, Mylan Technologies, Actavis Labs Ut Inc, Mayne Pharma, Boehringer Ingelheim, Hikma Farmaceutica, Zydus Pharms Usa Inc, Duramed Pharms Barr, Prinston Inc, Teva, Luitpold, Mylan Institutional, Mylan, Actavis Elizabeth, Frontida Biopharm, Sun Pharm Inds Inc, Concordia Pharms Inc, Warner Chilcott, Interpharm, Par Pharm, Watson Labs, Exela Pharma Scs Llc, Alembic Pharms Ltd, Fresenius Kabi Usa, Am Therap, Anchen Pharms, Chartwell Molecules, Aurolife Pharma Llc, Unichem, Yung Shin Pharm, and Impax Labs, and is included in sixty-two NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are twenty-one drug master file entries for clonidine. Nine suppliers are listed for this compound.

Summary for Generic Name: clonidine

Tradenames:9
Patents:1
Applicants:32
NDAs:62
Drug Master File Entries: see list21
Suppliers / Packagers: see list9
Bulk Api Vendors: see list36
Clinical Trials: see list219
Patent Applications: see list6,585
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:clonidine at DailyMed

Pharmacology for Ingredient: clonidine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Boehringer Ingelheim
CATAPRES
clonidine hydrochloride
TABLET;ORAL017407-003Approved Prior to Jan 1, 1982ABRXYesYes► Subscribe► Subscribe
Tris Pharma Inc
CLONIDINE
clonidine
TABLET, EXTENDED RELEASE;ORAL022500-002Dec 3, 2009DISCNNoNo► Subscribe► Subscribe
Impax Labs
CLONIDINE HYDROCHLORIDE
clonidine hydrochloride
TABLET;ORAL078099-003Aug 27, 2009ABRXNoNo► Subscribe► Subscribe
Aurolife Pharma Llc
CLONIDINE HYDROCHLORIDE
clonidine hydrochloride
TABLET;ORAL070887-001Aug 31, 1988DISCNNoNo► Subscribe► Subscribe
Tris Pharma Inc
CLONIDINE
clonidine
SUSPENSION, EXTENDED RELEASE;ORAL022499-001Dec 3, 2009DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: clonidine

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Boehringer Ingelheim
CATAPRES-TTS-3
clonidine
FILM, EXTENDED RELEASE;TRANSDERMAL018891-003Oct 10, 19843,996,934► Subscribe
Boehringer Ingelheim
CATAPRES-TTS-1
clonidine
FILM, EXTENDED RELEASE;TRANSDERMAL018891-001Oct 10, 19844,559,222► Subscribe
Boehringer Ingelheim
CATAPRES-TTS-2
clonidine
FILM, EXTENDED RELEASE;TRANSDERMAL018891-002Oct 10, 19843,454,701► Subscribe
Boehringer Ingelheim
CATAPRES-TTS-1
clonidine
FILM, EXTENDED RELEASE;TRANSDERMAL018891-001Oct 10, 19843,454,701► Subscribe
Boehringer Ingelheim
CATAPRES-TTS-2
clonidine
FILM, EXTENDED RELEASE;TRANSDERMAL018891-002Oct 10, 19843,996,934► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
AstraZeneca
McKinsey
Chubb
Baxter
Queensland Health
Moodys
Chinese Patent Office
Citi
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot